The company reported earnings of $34.3 million for the quarter, compared to $26.8 million during the same period last year. When adjusting for one-time items, LivaNova delivered $1.23 per share, comfortably surpassing the $1.06 average estimate tracked by FactSet. While total revenue grew 10% to $393.1 million, the result fell short of the $428.6 million analysts had anticipated.
In section Market Quotes
LivaNova Shares Surge as Earnings Guidance Tops Analyst Expectations
LivaNova shares climbed 12% to $89.94 in Wednesday's premarket trading after the medical-device manufacturer raised its full-year earnings and revenue growth forecasts. The Gloucester-based company beat profit expectations for the quarter, signaling stronger operational momentum despite a revenue figure that landed slightly below Wall Street estimates.
Looking ahead, management signaled confidence by lifting its 2026 adjusted earnings target to a range of $4.40 to $4.50 per share, up from the previous $4.30 to $4.40 guidance. Furthermore, the firm increased its constant-currency revenue growth forecast to between 9% and 10%, improving upon its earlier projection of 8% to 9%.
Comments (0)
No comments yet. Be the first!